Citius Oncology (CTOR) Debt Ratio (2021 - 2026)

Citius Oncology (CTOR) has reported Debt Ratio for 6 consecutive years, with 0.03 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Debt Ratio fell 18.18% year-over-year to 0.03 in Q2 2026; TTM through Jun 2026 was 0.03, a 18.18% decrease from a year earlier, with the FY2025 full-year figure at 0.08, up 67.16% from the prior year.
• Debt Ratio was 0.03 for Q2 2026 at Citius Oncology, down from 0.04 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.75 in Q3 2022 and troughed at 0.02 in Q4 2023.
• A 5-year average of 0.1 and a median of 0.04 in 2026 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 131.07% in 2024 and declined 18.18% in 2026, its largest moves.
• Over 5 years, Debt Ratio stood at 0.75 in 2022, then slumped by 97.58% to 0.02 in 2023, then soared by 131.07% to 0.04 in 2024, then retreated by 17.72% to 0.03 in 2025, then fell by 1.89% to 0.03 in 2026.
• The last three Debt Ratio figures came in at 0.03 (Q2 2026), 0.04 (Q1 2026), and 0.03 (Q4 2025), per Business Quant data.